Simplex Trading’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,381
Closed -$3K 8925
2025
Q3
$3K Buy
+20,381
New +$24.4K ﹤0.01% 8495
2024
Q4
Sell
-5,162
Closed -$16.4K 8784
2024
Q3
$31K Buy
+5,162
New +$28.4K ﹤0.01% 6324
2024
Q2
Sell
-4,329
Closed -$27.5K 9032
2024
Q1
$36K Buy
4,329
+147
+4% +$1.28K ﹤0.01% 6580
2023
Q4
$27K Buy
4,182
+513
+14% +$2.53K ﹤0.01% 6658
2023
Q3
$11K Sell
3,669
-2,020
-36% -$5.82K ﹤0.01% 7098
2023
Q2
$15K Buy
+5,689
New +$16.7K ﹤0.01% 7025
2023
Q1
Sell
-241
Closed -$708 9290
2022
Q4
$0 Sell
241
-109
-31% -$313 ﹤0.01% 9472
2022
Q3
$0 Buy
+350
New +$922 ﹤0.01% 10139

Simplex Trading's EPIX Position: Q4 2025 in Review

Simplex Trading sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 20,381 shares — an estimated $3K sold.

Simplex Trading first reported a position in EPIX in Q3 2022 and held it in 8 quarters. The position peaked at $36K in Q1 2024. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

  • Simplex Trading reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 20,381 ESSA Pharma shares in Q4 2025, an estimated $3K.
  • Simplex Trading first reported a position in ESSA Pharma in Q3 2022 and held it in 8 quarters.
  • Simplex Trading's ESSA Pharma position peaked at $36K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.